Five months after signing off on Utility Therapeutics’ Pivya as the first new treatment for uncomplicated urinary tract infections (uUTIs) in more than two decades, the FDA is weighing the pros ...

DeepWell said it has received a groundbreaking clearance from the FDA for games and interactive media to treat mental health ...

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501 ...

Company to present new data, highlighting progress in its therapeutics program for recurrent glioblastoma (rGBM)AUSTIN, Texas ...

Hamilton, Bermuda, Sept. 19, 2024 (GLOBE NEWSWIRE) -- $4 million upfront with up to an additional $8 million of aggregate gross proceeds upon ...

Lasso peptides are natural products made by bacteria. Their unusual lasso shape endows them with remarkable stability, protecting them from extreme conditions ...

Application error: a client-side exception has occurred (see the browser console for more information).

In a report released today, Akash Tewari from Jefferies upgraded Relay Therapeutics (RLAY – Research Report) to a Buy, with a price ...

New machine learning techniques plumb vast "data lakes" to help researchers design faster, cheaper, more effective clinical ...

ARD-101, Aardvark Therapeutics' lead compound ... CCK production in PWS patients has been implicated as a key driver of hyperphagia. In addition to utility in treating PWS, the ability to suppress ...

About Coya Therapeutics, Inc. Headquartered in Houston ... the rate and degree of market acceptance and clinical utility of our product candidates; the size and growth potential of the markets for our ...